NASDAQ : POM
Pomdoctor Limited — Key statistics
Healthcare · Medical Care Facilities · China
Last price 1.99 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 5.53M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 4.28M |
| Enterprise Value | 68.69M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 2.58M |
| Shares Outstanding | 2.78M |
| Shares Change (YoY) | +143.37% |
| Shares Change (QoQ) | +77.63% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.07 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 0.35 |
| Quick Ratio | 0.27 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.96 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -352.09% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 250.75% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $366,204 |
| Profits Per Employee | -$330,184 |
| Employee Count | 165 |
| Asset Turnover | 6.84 |
| Inventory Turnover | 59.66 |
Taxes
| Measure | Value |
|---|
| Income Tax | 9,938 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | n/a |
| 52-Week Price Change | -98.26% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 2.92 |
| Relative Strength Index (RSI) | 54.08 |
| Average Volume (20 Days) | 6,289,310 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 22,500 |
| Short Previous Month | 25,966 |
| Short % of Shares Out | 0.12% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.33 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 60.42M |
| Gross Profit | 7.25M |
| Operating Income | -49.76M |
| Pretax Income | -55.70M |
| Net Income | -54.48M |
| EBITDA | -49.73M |
| EBIT | -49.76M |
| Loss Per Share | -$30.07 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 1.86M |
| Total Debt | 66.27M |
| Net Cash | -64.41M |
| Net Cash Per Share | -$23.17 |
| Equity (Book Value) | -74.51M |
| Book Value Per Share | -29.87 |
| Working Capital | -20.19M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -18.53M |
| Capital Expenditures | -214,474 |
| Depreciation & Amortization | 31,330 |
| Net Borrowing | -667,353 |
| Free Cash Flow | -18.74M |
| FCF Per Share | -$6.74 |
Margins
| Measure | Value |
|---|
| Gross Margin | 12.00% |
| Operating Margin | -82.35% |
| Pretax Margin | -92.19% |
| Profit Margin | -90.16% |
| EBITDA Margin | -82.29% |
| EBIT Margin | -82.35% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -143.37% |
| Shareholder Yield | -143.37% |
| Earnings Yield | -1,952.69% |
| FCF Yield | -437.73% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Oct 21, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -61.19 |
| Piotroski F-Score | 2 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |